StonvexLoading…
StonvexCore line items from MKL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $5.24B | $4.00B | $3.13B | $2.42B |
Operating Income | $-93.34M | $3.24B | $1.27B | $2.48B |
Net Income | $-216.28M | $2.42B | $816.03M | $1.79B |
EPS (Diluted) | $-23.72 | $176.38 | $55.63 | $129.07 |
Total Assets | $49.79B | $48.48B | $41.71B | $37.47B |
Total Liabilities | $36.05B | $33.28B | $28.65B | $26.22B |
Cash & Equivalents | $4.14B | $3.98B | $4.34B | $3.07B |
Free Cash Flow OCF − CapEx | $2.45B | $2.13B | $1.64B | $1.15B |
Shares Outstanding | 13.58M | 13.80M | 13.82M | 13.79M |